"p.s. how much are you down tiger? And why are you still a...

First 19 Last

Share
Profile

Follow
TerribleTadpole

4,781 Posts.

2350

01/04/24

15:56

Post #: 73135974
Share

Originally posted by Stagflation: ↑

Expecting a re-rate due to the fact they now have sufficient funds to reach the most key milestones in the companies history. The recent raise sellers that wanted out as they are more focused on their fee's for putting the deal together, or a quick profit are mostly out judging by the multiple on screen sell amounts of around 1.2m shares (aka $30k new shares in the raise).

The nourish agreement which will speed up implementation (their major weakness) and factoring in FDA approval where only a fraction of the overall market need to take up the app for Painchek to turn a profit. Launch of infants app too. As well as Director participation in the recent raises after not buying on market for the whole pandemic period as they assessed if the business would survive. Lastly, the volume of buying this week, myself included

I expect the stock to re-rate or move consistently higher from here unless the US markets craps the bed.

p.s. how much are you down tiger? And why are you still a "Held, Hold" given your bearish sentiment. Happy Easter!

Expand

"p.s. how much are you down tiger? And why are you still a "Held, Hold" given your bearish sentiment." - Not down at all. I've been buying a few here since late 2022 based on expectations that the company is pivoting to commercial operation. My average price for the lot by February this year was just under 31c. When the CR was announced I churned out the lot (except 500 shares to maintain eligibility) for 32c and got them back in the CR. So "held" because I hold. Hold because still believe the company is making the transition to commercial operation.

PCK Price at posting: 3.2¢ Sentiment: Hold Disclosure: Held
Upvote

1 Great analysis

Reply